Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.
D000740:Anemia / Q000209:etiology; D001380:Azauridine / Q000627:therapeutic use; D001772:Blood Cell Count; D001792:Blood Platelets; D001856:Bone Marrow Examination; D002066:Busulfan / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000097:blood* / Q000150:complications / Q000175:diagnosis; D008936:Mitolactol / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010649:Phenylalanine; D055728:Primary Myelofibrosis / Q000209:etiology; D011379:Prognosis; D013163:Splenomegaly / Q000209:etiology; D013922:Thrombocytosis / Q000188:drug therapy / Q000209:etiology*
D009588:Nitrogen Mustard Compounds; D010649:Phenylalanine; D001380:Azauridine; D002066:Busulfan; D008936:Mitolactol; D006918:Hydroxyurea